Mr. Jim Breslin:

As I have said, I had a formal briefing on the issue when I returned in September 2018. I later had a meeting of the board of the Children's Hospital Programme Project in mid-September. I got a verbal update from the project director at that meeting and that allowed us to interrogate what the issues were. At the previous board meeting, I think it was in June, we would certainly have been informed of the delay in the GMP process. We would also have been informed that it might have had to be extended and that difficulty was being experienced with the contractors on the GMP process. Quite an aggressive stance was being taken, particularly with collaboration on value engineering where there was an attempt to make savings.